Testosterone Dosage Guide for Women

Key Takeaways: Female testosterone dosing is roughly 1/10th to 1/20th of male dosing. Start at 2.5-5 mg/day topical, titrate to 5-10 mg/day based on blood work and symptoms. Target total testosterone is 50-70 ng/dL. Always start low and go slow. Signs of overdosing include acne, facial hair growth, and voice changes.

The Fundamental Rule: Start Low, Go Slow

Female testosterone dosing requires a different mindset than male TRT. In men, the target range is 700-1100 ng/dL. In women, the target is 50-70 ng/dL. The margin between therapeutic benefit and unwanted side effects is narrower, which means precision matters.

The approach:

1. Start at the low end of the dosing range
2. Check blood work at 6-8 weeks
3. Adjust in small increments (2.5 mg/day) every 4-6 weeks
4. Prioritize symptom response alongside blood levels
5. Be patient -- full effects take 3-6 months

Working with a provider experienced in women's hormone therapy makes this process safer and more effective. Find a vetted clinic that specializes in female TRT.

Dosing by Delivery Method

Testosterone Cream

The most commonly prescribed form for women. Compounded at concentrations suitable for the small doses women need.

Phase	Dose	Volume (1% cream)	Duration
Starting	2.5-5 mg/day	0.25-0.5 mL	6-8 weeks
Low maintenance	5 mg/day	0.5 mL	Ongoing
Standard maintenance	7.5 mg/day	0.75 mL	Ongoing
Upper maintenance	10 mg/day	1.0 mL	Ongoing

Application: Apply once daily, preferably in the morning. Inner thigh is the most common site. Rotate between left and right thigh.

Measurement: Most compounding pharmacies provide a graduated syringe or pump mechanism for precise dosing. If using a tube, measure carefully -- small volume differences significantly affect the dose.

Read the full guide on Testosterone Cream for Women.

Testosterone Gel

Similar dosing to cream, with slightly different absorption characteristics.

Phase	Dose	Notes
Starting	2.5-5 mg/day	Apply to inner forearm or thigh
Maintenance	5-10 mg/day	Titrate based on levels and symptoms

Gel absorption may be slightly faster than cream due to the alcohol base. Some women find they need slightly lower doses with gel compared to cream. Blood work at 6-8 weeks clarifies the individual response.

See our Testosterone Gel for Women guide for more detail.

Testosterone Pellets

Pellet dosing is expressed as total milligrams per insertion, not daily dose. The pellets dissolve over 3-4 months, providing a slow, steady release.

Patient profile	Dose per insertion	Pellets	Expected duration
First pellet insertion	50 mg	1-2 pellets	3-4 months
Standard maintenance	62.5-75 mg	2-3 pellets	3-4 months
Higher maintenance	75-100 mg	2-4 pellets	3-4 months
Post-oophorectomy	75-100 mg	2-4 pellets	3-4 months

Important: Once pellets are inserted, the dose cannot be reduced. This is why first-time pellet patients should start conservatively. If you have not yet established your optimal dose with cream or gel, consider doing so before switching to pellets.

Full pellet guide: Testosterone Pellets for Women.

Other Methods (Less Common)

DHEA (oral): 10-25 mg/day. DHEA is a precursor that converts to testosterone, but conversion rates are unpredictable (10-15% on average). Blood levels of testosterone after DHEA supplementation vary widely between individuals. Not recommended as a primary testosterone replacement strategy.

Intramuscular injection: Rarely used in women. The lowest available testosterone cypionate concentration (200 mg/mL) makes it difficult to accurately draw up the 2-5 mg doses women need. Some compounding pharmacies produce lower-concentration injectables (20-40 mg/mL), but topical delivery is preferred for consistency.

Sublingual troches: Compounded testosterone troches dissolve under the tongue. Doses of 0.5-2 mg twice daily are used by some clinicians. Absorption is rapid but levels fluctuate more than topical methods. Limited clinical data in women.

Target Blood Levels

Total Testosterone

Target range: 50-70 ng/dL

This corresponds to the upper range of normal for premenopausal women. It is the range most clinicians associate with optimal symptom resolution.

Level	Interpretation
Below 25 ng/dL	Clearly deficient in most women
25-40 ng/dL	Low-normal; may be insufficient for symptom relief
40-50 ng/dL	Adequate for some women; may need optimization
50-70 ng/dL	Optimal therapeutic range
70-100 ng/dL	Above target; watch for androgenic side effects
Above 100 ng/dL	Supraphysiological; reduce dose

Free Testosterone

Free testosterone is the biologically active fraction. It should be measured by equilibrium dialysis (the gold standard) or calculated from total T, SHBG, and albumin.

Target: Upper quartile of the laboratory's female reference range.

Exact numbers vary by lab, but typical targets are 3-6 pg/mL (by equilibrium dialysis). The key is to ensure free testosterone is not suppressed by high SHBG, which is common in women taking oral estrogen.

SHBG Considerations

Sex hormone-binding globulin directly affects how much testosterone is bioavailable. High SHBG binds more testosterone, reducing the free fraction. Low SHBG allows more free testosterone, potentially amplifying effects at a given total T level.

Factors that increase SHBG (requiring higher testosterone doses):

• Oral estrogen therapy
• Hyperthyroidism
• Low body weight
• Aging

Factors that decrease SHBG (requiring lower testosterone doses):

• Insulin resistance/obesity
• Hypothyroidism
• Oral androgens
• PCOS

Titration Protocol

Week 1-6: Initial Phase

• Start at 2.5-5 mg/day (topical) or 50 mg (pellets)
• Apply consistently at the same time daily
• Track symptoms: libido, energy, mood, sleep, exercise recovery
• Note any side effects: acne, skin changes, hair changes

Week 6-8: First Assessment

• Blood work: total testosterone, free testosterone, SHBG, estradiol, CBC
• Timing: draw blood in the morning, before daily application (trough level for topicals), or 4-6 weeks post-insertion (for pellets)
• Review symptom diary

Decision Points After First Labs

Total T result	Free T result	Symptoms	Action
Below 40 ng/dL	Low	Not improved	Increase dose by 2.5 mg/day
40-50 ng/dL	Low-normal	Partially improved	Increase by 2.5 mg/day
40-50 ng/dL	Normal	Improved	May maintain or modestly increase
50-70 ng/dL	Normal	Improved	Maintain current dose
50-70 ng/dL	Normal	Not improved	Evaluate other causes; may not be testosterone-related
Above 70 ng/dL	High	Side effects	Decrease dose by 2.5 mg/day

Week 12-16: Second Assessment

• Repeat blood work if dose was adjusted
• Symptom improvement should be more apparent
• Fine-tune dosing

6-Month Evaluation

• Per the Global Consensus Position Statement, assess whether testosterone therapy is providing meaningful benefit
• If symptoms have not improved after 6 months at optimized levels, testosterone deficiency may not be the primary issue
• If benefits are clear, continue with monitoring every 6-12 months

Signs of Overdosing

Recognize these early and reduce the dose immediately:

Early Warning Signs (Reduce Dose)

• Acne, particularly along the jawline
• Increased oiliness of skin and hair
• Fine facial hair becoming darker or coarser
• Increased body hair growth
• Irritability or aggressive mood changes
• Disrupted sleep

Serious Signs (Stop and Consult Provider)

• Voice deepening or hoarseness
• Clitoral enlargement
• Significant scalp hair thinning (male pattern)
• Severe acne
• Menstrual irregularity (in premenopausal women not related to perimenopause)

Critical note: Voice deepening and clitoral enlargement may be irreversible. Do not ignore these symptoms. Acne and hair changes are generally reversible with dose reduction.

Special Dosing Considerations

Women on Oral Estrogen

Oral estrogen significantly increases hepatic SHBG production. This binds more testosterone and reduces the bioavailable fraction. Options:

1. Increase testosterone dose to compensate (may need 50-100% more than women not on oral estrogen)
2. Switch from oral to transdermal estrogen (patch or cream), which has less impact on SHBG
3. Monitor free testosterone specifically, not just total T

Women After Oophorectomy

Surgical menopause causes abrupt testosterone loss. These women often need doses at the higher end of the range (7.5-10 mg/day cream) and may benefit from faster titration since the deficiency is sudden and severe.

Younger Premenopausal Women

Dosing in younger women should be more conservative. Start at the lowest effective dose (2.5 mg/day) and titrate slowly. Monitor menstrual cycles for any irregularity. Effective contraception is essential if there is any pregnancy possibility, as testosterone can affect fetal development.

Women With PCOS History

Women with a history of PCOS may have increased androgen receptor sensitivity. Start at lower doses and monitor closely for hyperandrogenic symptoms. Target the lower end of the therapeutic range (total T 40-50 ng/dL).

For more on this, see Testosterone and PCOS.

Monitoring Schedule Summary

Timepoint	Labs to check
Baseline (before starting)	Total T, free T, SHBG, estradiol, progesterone, CBC, CMP, lipids
6-8 weeks	Total T, free T, SHBG
6 weeks after any dose change	Total T, free T, SHBG
6 months	Total T, free T, SHBG, CBC, lipids
Every 6-12 months (maintenance)	Total T, free T, SHBG, CBC, lipids, CMP annually

Related Reading

• Testosterone for Women: What You Need to Know
• Testosterone Cream for Women
• Women's TRT Side Effects
• How to Read Testosterone Labs

---

This content is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting any treatment.